Wednesday, March 9, 2016

ADRO Awaits Data In Q2, All Abuzz At OMER, RDHL Triumphs In H.pylori Study

Aduro Biotech Inc. (ADRO) has a couple of clinical trial catalysts to watch out for in the coming months.

from RTT - Biotech http://ift.tt/24Q4af9
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)